Barinthus Biotherapeutics (BRNS)
NASDAQ: BRNS
· Real-Time Price · USD
1.26
-0.02 (-1.25%)
At close: Aug 15, 2025, 3:59 PM
1.30
3.58%
After-hours: Aug 15, 2025, 05:41 PM EDT
-1.25% (1D)
| Bid | 1.02 |
| Market Cap | 50.23M |
| Revenue (ttm) | 5.8M |
| Net Income (ttm) | -65.22M |
| EPS (ttm) | -1.73 |
| PE Ratio (ttm) | -0.73 |
| Forward PE | -0.9 |
| Analyst | Buy |
| Ask | 1.46 |
| Volume | 13,314 |
| Avg. Volume (20D) | 1,261,388 |
| Open | 1.17 |
| Previous Close | 1.28 |
| Day's Range | 1.17 - 1.30 |
| 52-Week Range | 0.64 - 2.92 |
| Beta | -0.72 |
About BRNS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BRNS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BRNS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts9 months ago
+10.45%
Barinthus Biotherapeutics shares are trading highe...
Unlock content with
Pro Subscription
2 months ago · accessnewswire.com
Barinthus Biotherapeutics' CEO Bill Enright to Present at the Investor Summit Virtual on June 10, 2025OXFORD, GB AND GERMANTOWN, MD / ACCESS Newswire / June 9, 2025 / Barinthus Biotherapeutics plc announced that Bill Enright, CEO, will be presenting at the Investor Summit Virtual taking place on June ...